Apixaban Tablet 2.5 mg, 5 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg
Reference Brands: Eliquis(US /EU/ India)
Category: Blood Disorder
Apixaban tablets (2.5 mg, 5 mg) are a direct factor Xa inhibitor anticoagulant for preventing stroke in atrial fibrillation and for treating and preventing deep vein thrombosis and pulmonary embolism. It does not need routine INR monitoring. The originator is Eliquis (Bristol Myers Squibb/Pfizer); generic versions are sold in several markets while patents still apply in others. Patent status differs by country, so we confirm what can lawfully be supplied to your destination before quoting.
Manufacture or export Apixaban Tablet? List it or send an offer →
Product Description:
Apixaban is approved by regulatory authorities in both the EU and US for various indications, including stroke prevention in atrial fibrillation and treatment of DVT/PE. In the US, it is approved by the FDA, requiring a comprehensive dossier demonstrating safety, efficacy, and manufacturing quality. In the EU, approval is granted through the EMA’s centralized procedure, adhering to strict biosimilar and medicinal product standards. Accurate dossier preparation, including pharmacovigilance plans, stability data, and clinical trial evidence, is essential for market authorization. For expert guidance on regulatory strategy, dossier development, and market entry, visit PharmaTradz. Ensuring compliance facilitates smooth approval processes and successful commercialization worldwide.
Apixaban Tablet — third party manufacturing & bulk supply
Apixaban Tablet 2.5 mg, 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Apixaban Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Apixaban Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Apixaban Tablet →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Apixaban is used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Apixaban is a direct factor Xa inhibitor that works by selectively blocking factor Xa in the coagulation cascade, which reduces thrombin formation and prevents blood clot development.
The primary trade name is Eliquis, along with various generic brands available worldwide.
Apixaban is manufactured by Bristol-Myers Squibb in collaboration with Pfizer and is also produced by multiple pharmaceutical companies globally as a generic medicine.
The generic name is Apixaban.
Brand names include Eliquis and other regional generics.
Apixaban is manufactured in the USA, Europe, India, and other regions by multiple pharmaceutical companies under approved regulatory standards.
5 mg twice daily, reduced to 2.5 mg twice daily if a patient has at least two of: age 80 or over, weight 60 kg or less, or serum creatinine 1.5 mg/dl or higher.
Yes. Andexanet alfa reverses its effect in life-threatening bleeding; prothrombin complex concentrate is used where andexanet is not available.
Generics are marketed in the UK, several EU countries, India and other markets. In the US, generic launch has been delayed by patent settlements, so we confirm status for your destination.
Related Products
Rivaroxaban Tablets
Strength:
10 mg, 15 mg, 20 mg
Form: Tablet
Reference Brands: Xarelto(US & EU), Rivabloc (India), Rivax (LATAM)
View Details
Dabigatran Capsule
Strength:
75 mg, 110 mg, and 150 mg
Form: Capsules
Reference Brands: Pradaxa(EU & US)
View Details
Acenocoumarol Tablet
Strength:
1 mg, 2 mg, 4 mg
Form: Tablet
Reference Brands: Sintrom(EU)
View Details
Aspirin (Low Dose) Tablet
Strength:
81 mg
Form: Tablet
Reference Brands: Bayer Aspirin(US)
View Details
Anti-Inhibitor Coagulant Complex (Aicc) Lyophilized Powder
Strength:
500 units, 1000 units, and 2500 units
Form: Lyophilized Powder (Reconstituted for IV infusion)
Reference Brands: FEIBA(US)
View Details
Antihemophilic Factor
Strength:
250, 500, 1000, 1500, 2000 IU
Form: Injection
Reference Brands: Advate (USA), Afstyla (USA), Helixate FS (USA)
View Details
Concizumab-Mtci
Strength:
60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL
Form: Prefilled autoinjector
Reference Brands: Alhemo (USA/EU)
View Details
Usually answered within 48 hours | GMP documents shared before you commit
